Diagnostics & Precision Medicine
Developing affordable, patient-centred and fully-integrated clinical, AI and medical-device based systems. Its first product addresses neutropenic sepsis: the most fatal side-effect of chemotherapy.
Visit company siteUmaima Ahmad
CEO & Co-Founder
A technology company dedicated to unleashing the potential of genomics to transform human health by using their technology to remove the noise from genomic data.
Visit company siteDr Barnaby Balmforth
Co-Founder & CEO
CanCertain uses advanced 3D cell culture techniques to help both patients and oncologists find the optimal cancer treatment using their own cancer cells.
Visit company siteDharmesh Mehta
Business Development Director
Glyconics is developing a range of Miniaturized InfraRed (IR) products for use at point-of-care to produce diagnostic data in minutes, focussing initially on diabetes screening.
Visit company siteDr Kam Pooni
CEO
Lateral Dx is a contract development company specialising in Lateral Flow Technology. They have developed a fast, quantitative antibody screening system that delivers a cost-effective method of screening antibodies for use in Lateral flow tests (LFT).
Visit company siteRichard Campbell
Managing Director
Novel multi-omics liquid biopsy tests via Extracellular Vesicles (EVs) enabling the real time analysis of tissue-specific bioactivity in blood. Its first product is a blood test for early detection of liver cancer among high-risk patients.
Visit company sitePierre Arsene
Founder & CEO
Providing services to clients for the discovery of Antibody/ Autoantibody Biomarker Signatures.
Visit company siteAdam M Hill
CEO
Manufacturing point of care medical diagnostics that give results at the patient side within minutes.
Visit company siteDavid Campbell
Director
Using proprietary bioimpedance technology to characterise cell changes during disease progression which provides a status of disease for clinicians.
Visit company siteSameer Kothari
CEO
Category Winners
See our 2023 Category Winners
Meet our 6 Category Winners selected for being market leading
UK Innovators in life sciences.